Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy
However, detection of circulating GLP-1 is complicated owing to its rapid degradation and inactivation by dipeptidylpeptidase-4 (DPP-4), as well as its quick clearance from the systemic circulation 25
Fortunately, advances in medical science have introduced new, effective tools to support weight management, one of which is tirzepatide a medication that has gained attention for its impressive results in promoting weight loss in appropriate candidates
has received financial remuneration from Alnylam, Amgen, AstraZeneca, Crinetics, Eli Lilly, Insulet, Kallyope, Metsera, Pfizer and Sanofi for consulting and from Novo Nordisk for speaking, and Mt
R: Los estudios clnicos muestran resultados significativos entre 12 y 68 semanas de uso continuo
Roux en Y gastric bypass hypoglycemia resolves with gastric feeding or reversal: confirming a non-pancreatic etiology